company background image
531633 logo

Lincoln Pharmaceuticals BSE:531633 Stock Report

Last Price

₹628.20

Market Cap

₹12.4b

7D

-3.0%

1Y

57.9%

Updated

19 Jul, 2024

Data

Company Financials

Lincoln Pharmaceuticals Limited

BSE:531633 Stock Report

Market Cap: ₹12.4b

531633 Stock Overview

Engages in manufacturing and trading of pharmaceutical products in India and internationally.

531633 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends5/6

Lincoln Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lincoln Pharmaceuticals
Historical stock prices
Current Share Price₹628.20
52 Week High₹754.25
52 Week Low₹394.45
Beta0.73
11 Month Change4.06%
3 Month Change8.30%
1 Year Change57.90%
33 Year Change68.89%
5 Year Change331.90%
Change since IPO2,517.50%

Recent News & Updates

Recent updates

Shareholder Returns

531633IN PharmaceuticalsIN Market
7D-3.0%-0.8%-1.3%
1Y57.9%46.3%43.0%

Return vs Industry: 531633 exceeded the Indian Pharmaceuticals industry which returned 48.8% over the past year.

Return vs Market: 531633 exceeded the Indian Market which returned 44.7% over the past year.

Price Volatility

Is 531633's price volatile compared to industry and market?
531633 volatility
531633 Average Weekly Movement4.4%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 531633 has not had significant price volatility in the past 3 months.

Volatility Over Time: 531633's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19791,645Mahendrabhai Patelwww.lincolnpharma.com

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative, as well as dermatologist preparations, gynecological products, gastrointestinal rang, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It also offers branded generics.

Lincoln Pharmaceuticals Limited Fundamentals Summary

How do Lincoln Pharmaceuticals's earnings and revenue compare to its market cap?
531633 fundamental statistics
Market cap₹12.43b
Earnings (TTM)₹933.05m
Revenue (TTM)₹5.81b

13.5x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
531633 income statement (TTM)
Revenue₹5.81b
Cost of Revenue₹2.78b
Gross Profit₹3.02b
Other Expenses₹2.09b
Earnings₹933.05m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)46.58
Gross Margin52.06%
Net Profit Margin16.07%
Debt/Equity Ratio0.2%

How did 531633 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

4%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.